Editorial

By Karen E. Roman Alladapt Immunotherapeutics, Inc., a biopharmaceutical company developing treatment for Immunoglobulin E-mediated...

IPO Edge hosted a fireside chat with Chief Executive Officer Michael Seifert of PublicSq (NYSE:...

By PE Edge Editorial Staff Hodes Weill & Associates and Cornell University published their annual...

By Exec Edge Editorial Staff Iran’s interference in Iraq’s internal politics has been pernicious and...

    By Healthcare Edge Editorial Staff Octave Bioscience, Inc., a company offering treatment for...

  By Karen E. Roman SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage company developing a...

By Thomas S. Green Swiss athletic brand On Holding AG (NYSE: ONON) raised full-year sales...

The leading provider of AI-powered enterprise communications software is unlocking the true value of contact...

  By Karen E. Roman Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a company which...

By Karen E. Roman Alladapt Immunotherapeutics, Inc., a clinical-stage company which develops therapeutics to address...